DE69628844D1 - Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose - Google Patents

Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose

Info

Publication number
DE69628844D1
DE69628844D1 DE69628844T DE69628844T DE69628844D1 DE 69628844 D1 DE69628844 D1 DE 69628844D1 DE 69628844 T DE69628844 T DE 69628844T DE 69628844 T DE69628844 T DE 69628844T DE 69628844 D1 DE69628844 D1 DE 69628844D1
Authority
DE
Germany
Prior art keywords
leishmaniasis
diagnosis
therapy
leishmania antigens
leishmania
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69628844T
Other languages
English (en)
Other versions
DE69628844T2 (de
Inventor
G Reed
Antonio Campos-Neto
R Webb
C Dillon
A Skeiky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of DE69628844D1 publication Critical patent/DE69628844D1/de
Application granted granted Critical
Publication of DE69628844T2 publication Critical patent/DE69628844T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE69628844T 1995-09-22 1996-09-20 Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose Expired - Lifetime DE69628844T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US533669 1995-09-22
US08/533,669 US5834592A (en) 1995-09-22 1995-09-22 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
PCT/US1996/015185 WO1997011180A1 (en) 1995-09-22 1996-09-20 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis

Publications (2)

Publication Number Publication Date
DE69628844D1 true DE69628844D1 (de) 2003-07-31
DE69628844T2 DE69628844T2 (de) 2004-05-19

Family

ID=24126960

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69628844T Expired - Lifetime DE69628844T2 (de) 1995-09-22 1996-09-20 Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose

Country Status (9)

Country Link
US (2) US5834592A (de)
EP (1) EP0854924B1 (de)
AT (1) ATE243750T1 (de)
AU (1) AU7242796A (de)
BR (1) BRPI9610679B1 (de)
DE (1) DE69628844T2 (de)
ES (1) ES2205059T3 (de)
PT (1) PT854924E (de)
WO (1) WO1997011180A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013268A (en) 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US6607731B1 (en) 1995-09-22 2003-08-19 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6613337B1 (en) * 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6638517B2 (en) 1995-09-22 2003-10-28 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en) 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6375955B1 (en) * 1995-09-22 2002-04-23 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6365165B1 (en) 1995-09-22 2002-04-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
ATE530651T1 (de) * 1997-02-12 2011-11-15 Corixa Corp Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose
EP0981624A2 (de) * 1997-02-12 2000-03-01 Corixa Corporation Leishmania antigene zur verwendung in leishmaniasis therapie und diagnose
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
GB0008305D0 (en) * 2000-04-06 2000-05-24 Neutec Pharma Plc Treatment of fungal infections
US6673351B1 (en) 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis
US20040241168A1 (en) * 2001-03-16 2004-12-02 O'daly Jose A. Compositions and methods for the treatment and clinical remission of psoriasis
ES2323131T3 (es) * 2003-12-23 2009-07-07 All India Institute Of Medical Sciences Oligonucleotidos para la deteccion de leishmaniasis y metodos correspondientes.
AU2003288711A1 (en) * 2003-12-26 2005-07-21 All India Institute Of Medical Sciences Polypeptides for the diagnosis and therapy of leishmaniasis
US7833534B2 (en) 2006-04-10 2010-11-16 Infectious Disease Research Institute Compounds and methods for diagnosis and treatment of leishmaniasis
ES2628743T3 (es) 2008-07-03 2017-08-03 Infectious Disease Research Institute Proteínas de fusión y su uso en el diagnóstico y tratamiento de la leishmaniasis
BR112015024860B1 (pt) 2013-03-28 2023-11-07 Access To Advanced Health Institute Polipeptídeo de fusão, polinucleotídeo isolado, composição compreendendo dito polipeptídeo, uso da dita composição para estimular uma resposta imune contra leishmania e método in vitro e kit de diagnóstico para detectar infecção por leishmania em uma amostra biológica
US10648014B2 (en) * 2014-05-05 2020-05-12 Purdue Research Foundation Degradation resistant peptide based biosensors
TR202006914A1 (tr) * 2020-05-04 2021-11-22 Univ Yeditepe İmmunoprofi̇lakti̇k ve i̇mmunoterapöti̇k olarak ekstraselüler vezi̇külleri̇ni̇n lei̇shmani̇asi̇s hastaliği i̇çi̇n kullanimi
FR3115681A1 (fr) 2020-11-04 2022-05-06 Vaxinano Vaccin therapeutique comprenant un antigene specifique d’une maladie n’atteignant pas le systeme nerveux central et des nanoparticules et son utilisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870006A (en) * 1986-07-24 1989-09-26 Codon Antigenic material for a chagas' disease detection system
US5411865A (en) * 1993-01-15 1995-05-02 Iasys Corporation Method of detecting anti-leishmania parasite antibodies
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
ATE206163T1 (de) * 1994-04-22 2001-10-15 Corixa Corp Verbindungen und methoden für die stimulierungen und die erhöhung von schutzimmunantworten und il- 12 herstellung
US5879687A (en) * 1994-04-22 1999-03-09 Corixa Corporation Methods for enhancement of protective immune responses
US5876735A (en) * 1994-04-22 1999-03-02 Corixa Corporation Methods for enhancement of protective immune responses
US6013268A (en) * 1994-04-22 2000-01-11 Corixa Corporation Methods for enhancement of protective immune responses
US5965142A (en) * 1995-08-04 1999-10-12 Corixa Corporation Polypeptides and methods for the detection of L. tropica infection
US5834592A (en) 1995-09-22 1998-11-10 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis
US6054135A (en) * 1996-11-14 2000-04-25 Corixa Compounds and methods for the detection and prevention of T. cruzi infection
US5744593A (en) * 1996-02-15 1998-04-28 Heska Corporation Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules

Also Published As

Publication number Publication date
US5834592A (en) 1998-11-10
US6709661B1 (en) 2004-03-23
MX9802284A (es) 1998-08-30
ES2205059T3 (es) 2004-05-01
EP0854924A1 (de) 1998-07-29
PT854924E (pt) 2003-11-28
ATE243750T1 (de) 2003-07-15
BR9610679A (pt) 1999-03-30
DE69628844T2 (de) 2004-05-19
EP0854924B1 (de) 2003-06-25
WO1997011180A1 (en) 1997-03-27
AU7242796A (en) 1997-04-09
BRPI9610679B1 (pt) 2017-05-16

Similar Documents

Publication Publication Date Title
ATE243750T1 (de) Leishmania-antigene zur anwendung in der leishmaniasis therapie und diagnose
ATE126706T1 (de) Hauttest und testkit für aids.
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
DE58908452D1 (de) Medizinisches Gerät zur Diagnose und/oder Therapie.
DE69535349D1 (de) Implantierbare aktive medizinische Vorrichtung mit Mittel zur Unterscheidung zwischen Ruhe- bzw. Aktivzustand des Patienten
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
ATE337399T1 (de) Zusammensetzungen zur immuntherapie und diagnose von tuberculosis
DE68911975D1 (de) Ophthalmoskopisches Diagnoseverfahren und Gerät.
ES2138729T3 (es) Metodos de diagnostico de la preeclampsia.
WO2001079276A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
KR950700726A (ko) 치료 또는 진단용 조성물, 그 제조방법 및 용도(composition for therapeutic or diagnostic use, process for its preparation and its use)
WO1998035045A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
DE10075036I2 (de) Impfstoff und Diagnostikum f}r den Schweine-Cholera-Virus.
NO912942D0 (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
WO2002098359A3 (en) Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
EP1422238A3 (de) Leishmania Antigene für Verwendung in der Therapie und Diagnose von Leishmaniose
NO892015D0 (no) Fremgangsmaate for fremstilling av et legemiddel.
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
SE9401919D0 (sv) Implanterbar anordning
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
OA08626A (en) Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections.
UA36246A (uk) Спосіб діагностики і препарування прихованих каріозних уражень апроксимальних поверхонь молярів нижче екватору
DE3676806D1 (de) Pharmazeutische zusammensetzung und behandlung.
NO901231D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition